Showing of 0 - 10 from 23 results
Gsk - Total results - 23
Nov 08, 2016
Compat overrules CCI's Rs 64 crore fine imposed on GlaxosmithKline, SanofiThe tribunal's order comes more than a year after the CCI had slapped Rs 64 crore fine on the two firms for alleged collusive bidding in supply of a meningitis vaccine to the government for Haj pilgrims
Oct 10, 2016
Dr Reddy's launches generic Lamotrigine tablets in USThe company's product is generic version of GSK Group of companies' Lamictal tablets
May 11, 2015
Hunt for AIDS cure accelerates as GSK and US experts link upBritain's GlaxoSmithKline , which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS.
Mar 03, 2015
Sun Pharma buys GSK's opiates biz in Australia: All you need to knowDrug major Sun Pharma will acquire GlaxoSmithKline's Opiates business in Australia for an undisclosed amount to strengthen its pain management portfolio. Both companies said they expect to close the deal by August.
Nov 23, 2014
Sebi eases rules on delisting but MNCs may be in no rush to delistSebi's board has eased the rules for delisting. Last year there was a deluge of open offers from MNCs to up stakes in their indian subsidiaries, but this time they may be in no rush to up stakes or delist
Sep 19, 2014
China fines drugmaker GSK record $489 mn in bribery case, sentences executivesChina has fined GlaxoSmithKline Plc a record 3 billion yuan ($488.8 million) for paying bribes to doctors to use its drugs, the British company said on Friday, drawing to a close a corruption probe that rocked the pharmaceutical sector in China.
Sep 09, 2014
US probe: GSK's China unit faces more than just bribery chargesGSK confirmed it had conducted an investigation into procurement practices in consumer healthcare in China, but said it did not find any "unethical conduct".<br />
Jul 22, 2014
Lupin, US firms plan bids for range of GSK drugs to be auctionedAssuming a multiple of between two and three times those sales, the assets on the block could fetch between $3.5 billion and $5.0 billion.<br />
Jan 20, 2014
Sameer Goel appointed as drug co Cipla's India chiefGoel, who comes to Cipla from GlaxoSmithKline (GSK), will be reporting to company's Managing Director and Global CEO Subhanu Saxena.<br /><br />
Jan 13, 2014
FIPB clears GSK's Rs 6,400 cr FDI proposal to hike stake in IndiaThe Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 percent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.